Presentation ESC 2018 The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Presenter: Marco Valgimigli August 26, 2018 REGISTER for free or LOG IN to view this content Coronary ACS/AMI DES/BRS/DCB Presentation ESC 2018 MATRIX trial Up Next Presentation ESC 2018 CULPRIT-SHOCK: Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock – 1-Year Results Presenter: Holger Thiele August 26, 2018 More slides + Presentation ESC 2018 FUnctional Testing Underlying REvascularization The FUTURE trial Presenter: Gilles Rioufol August 26, 2018 Presentation ESC 2018 Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results Presenter: Alex C. Spyropoulos August 27, 2018 We Recommend
Presentation ESC 2018 CULPRIT-SHOCK: Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock – 1-Year Results Presenter: Holger Thiele August 26, 2018
Presentation ESC 2018 FUnctional Testing Underlying REvascularization The FUTURE trial Presenter: Gilles Rioufol August 26, 2018
Presentation ESC 2018 Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results Presenter: Alex C. Spyropoulos August 27, 2018